Skip to content
10-Q

Quarterly Report

Carisma Therapeutics Inc.

0001628280-25-038922

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 41.79M sh
Shares Diluted Q2 2025 · Jun 30, 2025 41.79M sh
Shares Diluted Q2 2025 · Jun 30, 2025 41.78M sh
Shares Diluted Q2 2025 · Jun 30, 2024 41.54M sh
Shares Diluted Q2 2025 · Jun 30, 2024 41.24M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $123K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$15.97M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$38.55M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $2M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $17.91M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.95M
Current Liabilities Q2 2025 · Dec 31, 2024 $16.06M
Total Liabilities Q2 2025 · Jun 30, 2025 $51.02M
Total Liabilities Q2 2025 · Dec 31, 2024 $58.37M
Current Assets Q2 2025 · Jun 30, 2025 $4.3M
Current Assets Q2 2025 · Dec 31, 2024 $23.83M
Total Assets Q2 2025 · Jun 30, 2025 $5.01M
Total Assets Q2 2025 · Dec 31, 2024 $30.46M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.23
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.27
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.73
Eps Basic Q2 2025 · Jun 30, 2025 −$0.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.46
Eps Basic Q2 2025 · Jun 30, 2024 −$0.27
Eps Basic Q2 2025 · Jun 30, 2024 −$0.73
Sga Expense Q2 2025 · Jun 30, 2025 $3.35M
Sga Expense Q2 2025 · Jun 30, 2025 $7.26M
Sga Expense Q2 2025 · Jun 30, 2024 $5.56M
Sga Expense Q2 2025 · Jun 30, 2024 $11.01M
Rd Expense Q2 2025 · Jun 30, 2025 $2.42M
Rd Expense Q2 2025 · Jun 30, 2025 $11.58M
Rd Expense Q2 2025 · Jun 30, 2024 $15.31M
Rd Expense Q2 2025 · Jun 30, 2024 $32.77M
Net Income Q2 2025 · Jun 30, 2025 −$9.77M
Net Income Q2 2025 · Jun 30, 2025 −$19.04M
Net Income Q2 2025 · Mar 31, 2025 −$9.27M
Net Income Q2 2025 · Jun 30, 2024 −$11.16M
Net Income Q2 2025 · Jun 30, 2024 −$30.14M
Net Income Q2 2025 · Mar 31, 2024 −$18.98M
Operating Income Q2 2025 · Jun 30, 2025 −$5.78M
Operating Income Q2 2025 · Jun 30, 2025 −$15.11M
Operating Income Q2 2025 · Jun 30, 2024 −$11.67M
Operating Income Q2 2025 · Jun 30, 2024 −$31.18M
Revenue Q2 2025 · Jun 30, 2025 $3.7M
Revenue Q2 2025 · Jun 30, 2024 $12.6M